Episode Summary
This episode examines the World Health Organization's updated HIV clinical management guidelines, which represent significant advances in antiretroviral therapy optimization and HIV treatment strategies. The new WHO recommendations prioritize dolutegravir-based regimens as first-line therapy and introduce simplified treatment protocols designed to improve clinical outcomes for people living with HIV while accelerating progress toward ending AIDS as a public health threat by 2030. These evidence-based updates address treatment efficacy, prevention of mother-to-child transmission, and integrated tuberculosis care in resource-limited settings.
Key Topics Discussed
- WHO updated HIV clinical management recommendations and their global implementation impact
- Dolutegravir-based antiretroviral therapy as preferred first-line treatment option
- Second-line antiretroviral regimens: darunavir/ritonavir-based protocols replacing previous protease inhibitor recommendations
- Prevention of mother-to-child transmission (PMTCT) and vertical HIV transmission management
- Tuberculosis preventive treatment options and integrated HIV-TB care services
- Long-acting injectable antiretroviral therapies and simplified treatment regimens for accessibility
Key Takeaways
- Dolutegravir-based regimens demonstrate superior effectiveness, resistance barrier strength, and tolerability profiles compared to alternative first-line options
- Updated second-line treatment protocols now favor darunavir/ritonavir-based combinations, reflecting current clinical evidence and improved safety outcomes
- Simplified antiretroviral regimens enhance treatment adherence and accessibility, particularly in resource-limited healthcare settings where HIV treatment burden remains significant
- Shortened tuberculosis preventive treatment durations and integrated HIV-TB service delivery strengthen comorbidity management for coinfected populations
- Long-acting injectable antiretroviral therapies expand treatment options and improve patient convenience and medication adherence
About This Episode
These updated WHO guidelines represent critical advances in global HIV clinical management, directly impacting treatment protocols across all healthcare settings. The recommendations address clinical practice in Georgia and worldwide, emphasizing evidence-based optimization of antiretroviral therapy, improved prevention strategies, and strengthened tuberculosis co-management. By simplifying treatment regimens and introducing long-acting formulations, these guidelines enhance accessibility and effectiveness for vulnerable populations, supporting the global commitment to eliminate AIDS as a public health threat by 2030.
In this episode of the GMJ Podcast — the official podcast of the Georgian Medical Journal, we examine the updated recommendations released by the World Health Organization on HIV clinical management.
The new guidance reflects major advances in HIV treatment science and aims to improve outcomes for people living with HIV while accelerating global progress toward ending AIDS as a public health threat by 2030.
The updated recommendations focus on optimizing antiretroviral therapy, improving prevention of mother-to-child transmission and strengthening tuberculosis prevention among people living with HIV.
WHO reaffirmed that dolutegravir-based antiretroviral regimens remain the preferred treatment option, due to their high effectiveness, strong resistance barrier and good tolerability.
The guidance also introduces updated recommendations for second-line treatment, now favoring darunavir/ritonavir-based regimens over previously recommended protease inhibitors.
In addition, the new recommendations highlight:
• simplified antiretroviral treatment regimens
• improved management of vertical HIV transmission
• shorter tuberculosis preventive treatment options
• the role of long-acting injectable antiretroviral therapies
• strengthening integrated HIV and TB care services
These updates reflect emerging clinical evidence and aim to make HIV care simpler, safer and more accessible, particularly in resource-limited settings where most people living with HIV receive treatment.
The WHO emphasizes that improved treatment strategies, combined with expanded prevention programmes and earlier diagnosis, remain essential for achieving the global goal of ending AIDS as a public health threat by 2030.
Original WHO source discussed in this episode:
https://www.who.int/news/item/07-01-2026-who-releases-updated-recommendations-on-hiv-clinical-management
The GMJ Podcast accompanies peer-reviewed publications and global health policy discussions published in the Georgian Medical Journal.
Journal website:
https://gmj.ge/index.php/pub/index
#გიორგიფხაკაძე #drpkhakadze #sheniekimi